 |
|
Current Trends in the Pharmacotherapy for Peptic Ulcer Disease
Lee J Hixson, MD;
Catherine L. Kelley, PharmD;
William N. Jones, MS;
Craig D. Tuohy, MD
Arch Intern Med. 1992;152(4):726-732.
Abstract
A variety of options are available for the medical treatment of peptic ulcer disease, including antacids, histamine2 receptor antagonists, omeprazole, prostaglandin analogues, and sucralfate and bismuth formulations. Seventy percent to 90% of peptic duodenal and gastric ulcers will heal after 4 to 8 weeks of therapy. Combination regimens using these agents have not been demonstated to be superior to singleagent therapy. Aggressive acid suppression with "highdose" histamine2 receptor antagonists or omeprazole accelerates healing of ordinary ulcers and promotes healing of previously refractory ulcers. Although ulcer recurrence is diminished by continuous "maintenance" therapy with the aforementioned agents, recurrence seems to be dramatically suppressed after eradication of Helicobacter pylori from the gastroduodenal mucosa.
(Arch Intern Med. 1992;152:726-732)
Author Affiliations
From the Medical (Drs Hixson and Tuohy) and Pharmacy (Dr Kelley and Mr Jones) Services, Veterans Affairs Medical Center and Colleges of Medicine and Pharmacy, University of Arizona, Tucson.
Footnotes
Accepted for publication August 27, 1991.
Reprint requests to University Medical Center, GI Section, Room 6406, 1501 N Campbell Ave, Tucson, AZ 85724 (Dr Hixson).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Helicobacter pylori
Fennerty
Arch Intern Med 1994;154:721-727.
ABSTRACT
Long term acid suppressing treatment in general practice
Ryder et al.
BMJ 1994;308:827-830.
ABSTRACT
| FULL TEXT
|
